SMS PHARMACEUTICALS
Back to Income Statement
|
SMS PHARMACEUTICALS Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹69 Cr | ₹50 Cr | ₹-7.06 Cr | ₹62 Cr | ₹63 Cr |
What is the latest Consolidated Net Profit of SMS PHARMACEUTICALS ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹69 Cr |
| Mar2024 | ₹50 Cr |
| Mar2023 | ₹-7.06 Cr |
| Mar2022 | ₹62 Cr |
| Mar2021 | ₹63 Cr |
How is Consolidated Net Profit of SMS PHARMACEUTICALS Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹69 Cr | 38.75 | |
| Mar2024 | ₹50 Cr | Positive | |
| Mar2023 | ₹-7.06 Cr | Negative | |
| Mar2022 | ₹62 Cr | -0.49 | |
| Mar2021 | ₹63 Cr | - | |
Compare Consolidated Net Profit of peers of SMS PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SMS PHARMACEUTICALS | ₹3,431.3 Cr | -1.1% | -0.4% | 100.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,528.0 Cr | -3.1% | 1.6% | 5.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹158,686.0 Cr | -1.5% | -3.4% | 9.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹142,457.0 Cr | -4.1% | -1.2% | 40.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,339.0 Cr | -1.5% | -0.9% | 16.8% | Stock Analytics | |
| CIPLA | ₹100,056.0 Cr | -5.7% | -7.8% | -13.2% | Stock Analytics | |
SMS PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SMS PHARMACEUTICALS | -1.1% |
-0.4% |
100.7% |
| SENSEX | -2.4% |
-10.9% |
0.2% |
You may also like the below Video Courses